ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/08/22 | 2,500 | 2,547 | 2,458 | 2,475 | -1 | ±0% | 2,088,300 |
2019/08/21 | 2,510 | 2,547 | 2,471 | 2,476 | -35 | -1.4% | 1,944,300 |
2019/08/20 | 2,419 | 2,519 | 2,394 | 2,511 | +86 | +3.5% | 2,460,300 |
2019/08/19 | 2,450 | 2,460 | 2,326 | 2,425 | +12 | +0.5% | 3,579,900 |
2019/08/16 | 2,569 | 2,628 | 2,375 | 2,413 | -129 | -5.1% | 8,034,700 |
2019/08/15 | 2,633 | 2,659 | 2,539 | 2,542 | -146 | -5.4% | 4,507,500 |
2019/08/14 | 2,698 | 2,777 | 2,660 | 2,688 | -29 | -1.1% | 5,351,500 |
2019/08/13 | 2,647 | 2,750 | 2,640 | 2,717 | +64 | +2.4% | 4,130,000 |
2019/08/09 | 2,568 | 2,690 | 2,550 | 2,653 | +105 | +4.1% | 3,763,600 |
2019/08/08 | 2,645 | 2,667 | 2,521 | 2,548 | -83 | -3.2% | 3,978,700 |
2019/08/07 | 2,712 | 2,731 | 2,621 | 2,631 | -64 | -2.4% | 2,707,100 |
2019/08/06 | 2,597 | 2,715 | 2,560 | 2,695 | -2 | -0.1% | 5,662,300 |
2019/08/05 | 2,567 | 2,794 | 2,501 | 2,697 | +153 | +6% | 12,351,800 |
2019/08/02 | 2,525 | 2,575 | 2,520 | 2,544 | -26 | -1% | 1,671,700 |
2019/08/01 | 2,520 | 2,599 | 2,487 | 2,570 | +22 | +0.9% | 2,528,700 |
2019/07/31 | 2,541 | 2,562 | 2,503 | 2,548 | -16 | -0.6% | 2,018,600 |
2019/07/30 | 2,531 | 2,574 | 2,518 | 2,564 | +33 | +1.3% | 2,338,000 |
2019/07/29 | 2,490 | 2,550 | 2,466 | 2,531 | +83 | +3.4% | 3,313,100 |
2019/07/26 | 2,487 | 2,539 | 2,441 | 2,448 | +7 | +0.3% | 3,474,200 |
2019/07/25 | 2,495 | 2,527 | 2,426 | 2,441 | -29 | -1.2% | 2,341,600 |
2019/07/24 | 2,447 | 2,499 | 2,410 | 2,470 | +32 | +1.3% | 2,698,500 |
2019/07/23 | 2,464 | 2,534 | 2,430 | 2,438 | -34 | -1.4% | 3,678,500 |
2019/07/22 | 2,580 | 2,587 | 2,459 | 2,472 | -137 | -5.3% | 4,534,200 |
2019/07/19 | 2,614 | 2,657 | 2,593 | 2,609 | +29 | +1.1% | 3,288,600 |
2019/07/18 | 2,638 | 2,675 | 2,550 | 2,580 | -70 | -2.6% | 6,755,700 |
2019/07/17 | 2,650 | 2,710 | 2,557 | 2,650 | +37 | +1.4% | 9,906,300 |
2019/07/16 | 2,223 | 2,773 | 2,150 | 2,613 | +340 | +15% | 18,634,200 |
2019/07/12 | 2,352 | 2,377 | 2,251 | 2,273 | -115 | -4.8% | 3,513,300 |
2019/07/11 | 2,358 | 2,430 | 2,320 | 2,388 | +7 | +0.3% | 2,846,000 |
2019/07/10 | 2,253 | 2,405 | 2,251 | 2,381 | +139 | +6.2% | 4,520,300 |
2019/07/09 | 2,271 | 2,323 | 2,216 | 2,242 | -14 | -0.6% | 2,245,400 |
2019/07/08 | 2,313 | 2,327 | 2,237 | 2,256 | -82 | -3.5% | 2,225,300 |
2019/07/05 | 2,304 | 2,344 | 2,237 | 2,338 | +40 | +1.7% | 2,294,000 |
2019/07/04 | 2,397 | 2,407 | 2,286 | 2,298 | -77 | -3.2% | 3,393,300 |
2019/07/03 | 2,470 | 2,475 | 2,355 | 2,375 | -65 | -2.7% | 3,687,800 |
2019/07/02 | 2,380 | 2,482 | 2,377 | 2,440 | +75 | +3.2% | 4,921,300 |
2019/07/01 | 2,399 | 2,429 | 2,340 | 2,365 | -4 | -0.2% | 3,499,700 |
2019/06/28 | 2,270 | 2,394 | 2,253 | 2,369 | +84 | +3.7% | 3,987,000 |
2019/06/27 | 2,339 | 2,364 | 2,217 | 2,285 | -52 | -2.2% | 3,736,600 |
2019/06/26 | 2,389 | 2,420 | 2,304 | 2,337 | +16 | +0.7% | 4,450,100 |
2019/06/25 | 2,300 | 2,360 | 2,258 | 2,321 | +6 | +0.3% | 4,617,500 |
2019/06/24 | 2,185 | 2,377 | 2,184 | 2,315 | +140 | +6.4% | 8,457,900 |
2019/06/21 | 2,139 | 2,238 | 2,121 | 2,175 | -1 | ±0% | 3,861,100 |
2019/06/20 | 2,079 | 2,184 | 2,030 | 2,176 | +106 | +5.1% | 3,750,800 |
2019/06/19 | 2,145 | 2,147 | 2,051 | 2,070 | -58 | -2.7% | 2,904,700 |
2019/06/18 | 2,086 | 2,133 | 2,063 | 2,128 | +49 | +2.4% | 2,738,900 |
2019/06/17 | 2,139 | 2,148 | 2,058 | 2,079 | -23 | -1.1% | 2,297,000 |
2019/06/14 | 2,030 | 2,123 | 2,023 | 2,102 | +82 | +4.1% | 2,991,400 |
2019/06/13 | 2,000 | 2,034 | 1,992 | 2,020 | +24 | +1.2% | 1,672,000 |
2019/06/12 | 1,988 | 2,043 | 1,969 | 1,996 | +18 | +0.9% | 2,761,700 |
1251~
1300
件表示中 / 4943件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 125,400円 | +197.7% | - | 0.00% | 51.24倍 | 1.64倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 349,000円 | +3.0% | +27.5% | 2.29% | 22.09倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
杏林製薬 | 153,700円 | +3.2% | +4.5% | 3.38% | 17.66倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム